The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...
Sally Pope Davis, a director at $UCB, bought 1,800 shares of the company on 03-11-2025 for an estimated $50,742. This trade was reported by Quiver Quantitative using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback